Transcript: Return to Sports Activities After Flexor Hallucis Longus Transfer for Neglected Achilles Tendon Rupture

Alex: Nearly a third of patients who had a tendon transfer for a neglected Achilles rupture ended up with a measurable decline in sports participation, even though overall outcomes were favorable. That comes from a retrospective analysis of Flexor Hallucis Longus transfer by Jungtae Ahn and Bi O. Jeong at Kyung Hee University.

Sam: That's a significant caveat. We usually frame this surgery as restoring the pre-injury baseline. If thirty-two percent of patients end up below it, is the procedure failing to restore the power needed for high-demand activity?

Alex: The data suggests the functional cost is real. In their cohort of twenty-eight patients, those whose Tegner Activity Scale score declined also had lower Achilles Tendon Total Rupture Scores. So the activity decline travels with worse patient-reported function. It isn't just a change in lifestyle.

Sam: So the surgery isn't a binary success or failure. Even if the graft is stable, functional output falls short for a subset. How does the transfer compensate for an Achilles that has degenerated?

Alex: Think of it as re-routing a power line. The native tendon is beyond repair, so the surgeon harvests the Flexor Hallucis Longus tendon, which normally flexes the big toe. It's passed through a drill hole in the heel bone and sutured to the Achilles stumps.

Sam: So a secondary muscle becomes the primary actuator for the heel. Does harvesting it create a new deficit that limits return to jogging or court games?

Alex: That's the obvious question. The Flexor Hallucis Longus is a robust biological substitute, but it isn't a biomechanical equivalent of the triceps surae complex. The authors suspect this is where the functional ceiling sits. But that's a hypothesis, not something the study tested.

Sam: Can they predict who ends up in the declining group?

Alex: Not from what they measured. They found no significant differences between the maintained and decreased activity groups in age, body mass index, or the interval between injury and surgery.

Sam: I'd be cautious about reading that as independence. With twenty-eight patients and a decline group of perhaps a third of them, the comparison has very little power. A null on age or delay to surgery could just mean the study couldn't detect it.

Alex: That's the right reading. Absence of a significant difference in a cohort this size isn't evidence of no effect. Combined with the retrospective design, it means the study can't tell us who is at risk. It can only say that those obvious candidates didn't separate the groups.

Sam: Then what's driving the decline? The lower scores might reflect a psychological barrier, such as fear of re-rupture, rather than a limit of the graft.